Natural Products from Litsea verticillata with Anti-HIV Activities
Author Information
Author(s): Yan Jia-Lei, Nan Huiru, Fang Xiaoyu, Long Xiong-En, Jiang Yu, Liu Junyang
Primary Institution: School of Pharmacy and Food Engineering, Wuyi University, Jiangmen, China
Hypothesis
The review aims to summarize the isolation and bioactivity of natural products from Litsea verticillata that exhibit anti-HIV activities.
Conclusion
Natural products isolated from Litsea verticillata show promising anti-HIV effects, particularly litseaverticillols B and E, but their selectivity indices indicate further optimization is needed for therapeutic use.
Supporting Evidence
- Litseaverticillol B demonstrated the most potent anti-HIV activity in vitro, with IC50 ranging from 2 to 3 μg/mL.
- Litseaverticillol E displayed the highest selectivity index (SI = 3.1), indicating a favorable balance between antiviral potency and cellular toxicity.
- Natural products from Litsea verticillata have garnered significant interest due to their unique structures and promising anti-HIV activities.
Takeaway
Scientists are studying a plant called Litsea verticillata to find new medicines that can help fight HIV. Some parts of the plant work well against the virus but can also harm healthy cells.
Methodology
The review summarizes various studies on the isolation and bioactivity of compounds from Litsea verticillata, including their anti-HIV activities and biosynthetic pathways.
Limitations
The selectivity indices of the most promising compounds are not optimal for therapeutic applications, indicating a need for further structural optimization.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website